Unlocking the Potential of a Powerful Medication | GLP-1s Exposed

30 May 2025 · 1 min
0:58

A short transcript excerpt from a May 30, 2025 YouTube video by Aaron Hartman, MD discussing GLP-1–class medications (e.g., semaglutide, tazeplatide), administration routes (injectable vs oral), dosing/cost considerations, and related agents such as berberine and metformin. The speaker links these medications and supplements to changes in metabolism via effects on the gut microbiome (noting increased Akkermansia muciniphila) and highlights potential therapeutic promise alongside dosing complexity.

Chapters

More from Aaron

53:04
youtube.com

Too Many Gut Fixes Can Undo Your Healing. What Helps It Last | Dr. Sabine Hazan

4d ago
6:54
youtube.com

Sometimes I Treat It Before I Know What Caused It

1w ago
45:33
youtube.com

Your Gut Keeps Its Own Age, and It Can Get Younger

1w ago
6:53
youtube.com

Lyme Is Supposed to Be Diagnosed Without a Blood Test

2w ago
1:18
youtube.com

Women’s Heart Attack Symptoms Differ From Men’s 95% of the Time — Only 30% Have Chest Pain #shorts

2w ago
1:42
youtube.com

Heart Disease Kills More Women Than All Cancers Combined — 80% of Cardiac Research Is on Men #shorts

2w ago
2:03
youtube.com

Women’s Physiology Was Systematically Ignored in Drug Research — The Consequences Are Still #shorts

2w ago
1:03:14
youtube.com

Why Cancer Comes Back Somewhere Else with Dr. Nasha Winters

2w ago
7:10
youtube.com

How Mold Became Too Common to Take Seriously

3w ago
2:37
youtube.com

It Took the FDA 20 Years to Realize Women Need Half the Dose of Ambien #shorts

3w ago
1:32
youtube.com

Until 1993, Women Were Banned From Clinical Drug Trials — Then Those Drugs Were Prescribed t #shorts

3w ago
See all content